Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 4,213-4,224 of 4,306
Drug study icon
CompletedNCT00240721

Effectiveness of effectiveness and Safety of Topiramate in Bipolarity

This study is completed. It is testing effectiveness and Safety of Topiramate for Bipolarity.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.Over 16 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00212797

2 Doses of Org 34517 for depression

This study is completed. It is testing 2 Doses of Org 34517 for depression.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Sponsor
Merck Sharp & Dohme LLC
Condition
Depression, Schizophrenia
Drug study icon
CompletedNCT00035802

Effectiveness of topiramate Compared to Placebo in Bipolarity

This study is completed. It is testing topiramate Compared to Placebo for Bipolarity.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 13 Years to 17 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Behavioral study icon
CompletedNCT04612777

A study of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Schizophrenia, ...BehavioralFrom 18 Years to 65 Years
Countries
Sponsor
New York State Psychiatric Institute
Condition
Depression, Schizophrenia, ...
Drug study icon
CompletedNCT06372210

A study to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

This summary needs review. Please check the official study record and contact the research team for details.

In Garden Grove
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Schizophrenia, ...DrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Schizophrenia, ...
Other study type icon
CompletedNCT02739932

Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Bipolarity, ...ObservationalA study where researchers collect information without assigning a treatment.From 12 Years to 25 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Depression, Bipolarity, ...
Behavioral study icon
TerminatedNCT05724953

Alexithymia Intervention for Suicide

This summary needs review. Please check the official study record and contact the research team for details.

In The Bronx
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, PTSD, ...BehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Depression, PTSD, ...
Drug study icon
CompletedNCT00510211

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Paris
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugOver 18 Years
Countries
France, Germany, Greece
Sponsor
Eli Lilly and Company
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT01670019

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Augusta
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Duke University
Condition
Depression, Schizophrenia
Device study icon
WithdrawnNCT00801567

Change in Brain Bioenergetics in Bipolarity in Response to Photic Stimulation

This summary needs review. Please check the official study record and contact the research team for details.

In Belmont
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.